AbCellera Biologics Inc. (ABCL) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
ABCL Stock Price Trajectory (2020–2026)
As of March 1, 2026, AbCellera Biologics Inc. (ABCL) trades at $3.61, representing a +39.4% return over the past year. The stock has delivered a -38.1% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $71.91 on December 11, 2020. From this peak, ABCL has corrected -95.0%, currently trading 10% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers REGN (+11.9% 1Y), CNTA (+72.7% 1Y), and IMNM (+132.6% 1Y), ABCL has underperformed the peer group average. Compare ABCL vs REGN →
Historical Price Data
Showing 30 of 1,309 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 3.44 | 3.62 | 3.36 | 3.61 | 3 | +0.56% |
| 2026-02-26 | 3.18 | 3.62 | 3.15 | 3.59 | 3 | +12.54% |
| 2026-02-25 | 3.36 | 3.39 | 3.13 | 3.19 | 3 | -0.93% |
| 2026-02-24 | 3.06 | 3.27 | 3.06 | 3.22 | 3 | +6.27% |
| 2026-02-23 | 3.00 | 3.12 | 2.98 | 3.03 | 3 | -0.33% |
| 2026-02-20 | 3.16 | 3.17 | 2.96 | 3.04 | 3 | -5.59% |
| 2026-02-19 | 3.12 | 3.23 | 3.06 | 3.22 | 2.00M | +2.88% |
| 2026-02-18 | 3.15 | 3.23 | 3.10 | 3.13 | 1.63M | +1.77% |
| 2026-02-17 | 3.09 | 3.11 | 3.06 | 3.08 | 208K | -0.78% |
| 2026-02-13 | 3.05 | 3.22 | 3.05 | 3.10 | 2.74M | +5.44% |
| 2026-02-12 | 3.20 | 3.20 | 2.93 | 2.94 | 3.80M | -6.07% |
| 2026-02-11 | 3.20 | 3.20 | 3.04 | 3.13 | 3.65M | -0.95% |
| 2026-02-10 | 3.28 | 3.28 | 3.14 | 3.16 | 1.93M | -1.86% |
| 2026-02-09 | 3.19 | 3.22 | 3.06 | 3.22 | 3.26M | +1.90% |
| 2026-02-06 | 2.94 | 3.17 | 2.88 | 3.16 | 5.38M | +13.67% |
| 2026-02-05 | 3.19 | 3.21 | 2.75 | 2.78 | 11.05M | -14.98% |
| 2026-02-04 | 3.51 | 3.53 | 3.18 | 3.27 | 6.56M | -7.10% |
| 2026-02-03 | 3.61 | 3.69 | 3.41 | 3.52 | 4.70M | +0.57% |
| 2026-02-02 | 3.57 | 3.65 | 3.50 | 3.50 | 6.14M | -3.31% |
| 2026-01-30 | 3.80 | 3.83 | 3.59 | 3.62 | 4.31M | -6.22% |
| 2026-01-29 | 3.90 | 3.91 | 3.75 | 3.86 | 2.43M | -1.03% |
| 2026-01-28 | 4.03 | 4.05 | 3.85 | 3.90 | 2.99M | -2.26% |
| 2026-01-27 | 4.16 | 4.25 | 3.95 | 3.99 | 3.21M | -3.62% |
| 2026-01-26 | 4.22 | 4.22 | 4.04 | 4.14 | 4.38M | -2.36% |
| 2026-01-24 | 4.67 | 4.67 | 4.19 | 4.24 | 5.75M | 0.00% |
| 2026-01-23 | 4.67 | 4.67 | 4.19 | 4.24 | 5.80M | -8.62% |
| 2026-01-22 | 4.38 | 4.85 | 4.35 | 4.64 | 6.97M | +8.41% |
| 2026-01-21 | 4.15 | 4.30 | 4.05 | 4.28 | 3.89M | +2.88% |
| 2026-01-20 | 3.97 | 4.21 | 3.92 | 4.16 | 3.87M | +0.97% |
| 2026-01-16 | 4.19 | 4.38 | 4.09 | 4.12 | 5.39M | -1.44% |
See ABCL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABCL Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ABCL vs AGIO
See how ABCL stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has ABCL stock performed recently?
ABCL returned +39.4% over the past year, beating its 5-year annualized CAGR of -38.1%. The stock trades below its 200-day moving average, confirming the uptrend.
What is ABCL's all-time high price?
AbCellera Biologics Inc. reached $71.91 on 2020-12-11. The 52-week high is $6.52. Current 1-year return of +39.4% places the stock closer to historical peaks.
Where can I download ABCL historical price data?
This page provides ABCL daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.